Kathryn M. Tully

An <i>in Vivo</i> Nanosensor Measures Compartmental Doxorubicin Exposure

Jackson D. Harvey, Ryan M. Williams, Kathryn M. Tully et al. · Nano Letters · 2019 · 59 citations

A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals

Sai Kiran Sharma, Serge K. Lyashchenko, Hijin A. Park et al. · Nuclear Medicine and Biology · 2019 · 55 citations · Full text

Engineering, Biochemistry, Medicine +13

Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer

Joshua A. Korsen, Julia Gutierrez, Kathryn M. Tully et al. · Proceedings of the National Academy of Sciences · 2022 · 52 citations · Full text

Bioorthogonal Masking of Circulating Antibody–TCO Groups Using Tetrazine-Functionalized Dextran Polymers

Jan‐Philip Meyer, Kathryn M. Tully, James Jackson et al. · Bioconjugate Chemistry · 2018 · 44 citations · Full text

Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer

Patrícia M. R. Pereira, Komal Mandleywala, Sébastien Monette et al. · Nature Communications · 2022 · 34 citations · Full text